Cholesteatoma

Look For First

On DWI: Hyperintense lesion on high b-value images (b = 1000) with restricted diffusion (low ADC values) — this is the pathognomonic MRI finding for cholesteatoma
On conventional MRI: T2 hyperintense lesion with T1 hypointense to isointense signal and no internal enhancement
On CT: Bone erosion of the scutum, ossicles, or lateral semicircular canal with possible tegmen tympani or facial nerve canal dehiscence
Location: Pars flaccida cholesteatomas originate in Prussak space and extend posteriorly; pars tensa cholesteatomas originate in posterior mesotympanum and extend posteromedially

Key Image Findings

On T1-weighted images: cholesteatoma appears hypointense to isointense to brain parenchyma without internal enhancement; thin peripheral enhancement may be present if surrounding inflammation or granulation tissue exists
On T2-weighted images: lesion is hyperintense, often appearing bright within the mastoid or middle ear
On DWI with high b-values (b = 1000): cholesteatoma shows hyperintense signal with restricted diffusion evidenced by low ADC values similar to brain parenchyma, providing near 100% specificity for diagnosis
On contrast-enhanced T1: no internal enhancement of the mass itself, distinguishing it from inflammatory or other enhancing pathology
Pars flaccida cholesteatoma: originates in the Prussak space and typically extends posteriorly; accounts for minority of cases
Pars tensa cholesteatoma: originates in posterior mesotympanum and extends posteromedially; represents the majority of acquired cholesteatomas
CT demonstrates excellent bony detail including erosion patterns: scutum erosion, ossicular erosion, lateral semicircular canal erosion, and dehiscence of facial nerve canal or tegmen tympani are critical findings for surgical planning
MRI can detect recurrent or residual cholesteatoma as small as a few millimeters with high sensitivity, making it superior to CT for post-operative follow-up and potentially obviating the need for second-look surgery

Differential Diagnosis

Cholesterol granuloma: shows high signal on ADC map (unrestricted diffusion) in contrast to cholesteatoma's restricted diffusion; may also occur in petrous apex with different clinical context
Inflammation/granulation tissue: appears hyperintense on T2 but demonstrates high ADC values and usually shows enhancement, unlike the restricted diffusion and lack of internal enhancement in cholesteatoma
Cerumen (earwax): can show similar imaging characteristics to cholesteatoma on conventional sequences but is located in the external ear canal rather than middle ear or mastoid; lacks the restricted diffusion on DWI
Abscess formation in middle ear: may show similar imaging findings on conventional MRI but has completely different clinical presentation and typically shows more extensive edema/enhancement of surrounding soft tissues
Congenital cholesteatoma: accounts for only 2% of cases and typically occurs without history of chronic otomastoiditis; imaging appearance is identical to acquired cholesteatoma

Discussion

Cholesteatoma is a benign but locally aggressive epithelial lesion lined by epithelium that continuously sheds keratin; the surrounding perimatrix contains inflammatory and enzymatic activity that drives bone erosion, making imaging crucial for assessing extent of disease

The term cholesteatoma is a medical misnomer: these are not neoplasms and do not contain cholesterol, but rather represent a chronic inflammatory condition with progressive epithelial proliferation

Acquired cholesteatoma (98% of cases) is subdivided into primary (no history of chronic otomastoiditis) and secondary; secondary disease arising from pars tensa or pars flaccida has distinct anatomic patterns of spread

DWI/ADC imaging with high b-values provides exceptional specificity for cholesteatoma diagnosis and is particularly valuable for detecting residual or recurrent disease post-operatively; this can reduce the need for second-look surgery

CT is essential for preoperative surgical planning to assess ossicular reconstruction needs and to exclude tegmen tympani perforation, while MRI excels at tissue characterization and small lesion detection

Special attention to the sinus tympani—the most hidden recess of the middle ear—is critical during imaging interpretation to avoid missing residual disease that could recur post-operatively

Reporting Pearls

When reporting cholesteatoma, clearly describe the location (pars flaccida vs. pars tensa, middle ear vs. mastoid vs. external canal), the presence or absence of bone erosion (specifically document scutum, ossicles, lateral semicircular canal, facial nerve canal, and tegmen tympani integrity), note whether the lesion extends into the sinus tympani or aditus ad antrum, and confirm the DWI/ADC restricted diffusion pattern to support the diagnosis; if post-operative, explicitly state whether findings are consistent with residual versus recurrent disease.

Pitfalls

False-positive diagnosis from cerumen impaction or debris in the external auditory canal or postoperative cavity: clear these structures before MRI examination to avoid misinterpretation
Mistaking inflammatory changes or cholesterol granuloma for cholesteatoma: key distinguishing feature is restricted diffusion (low ADC) in cholesteatoma versus high ADC in inflammatory lesions and cholesterol granuloma
Overlooking small residual or recurrent disease in the sinus tympani or other hidden recesses of the middle ear: systematically review all compartments of the temporal bone, especially on coronal DWI images
Relying on CT alone for diagnosis or post-operative surveillance: CT lacks specificity for detecting small lesions and cannot reliably distinguish acute inflammation from cholesteatoma; always supplement with MRI DWI/ADC

Cholesteatoma

Key Images

Secondary Links